Lexeo Therapeutics (LXEO) Current Assets (2022 - 2026)
Lexeo Therapeutics (LXEO) posted Current Assets of $217.91 million for Q2 2026, up 55.6% from $140.06 million a year earlier and up 8.5% from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Lexeo Therapeutics' Current Assets came in at $188.39 million, up 49.4% from FY2024.
- Annual Current Assets has increased for three consecutive years, with a three-year compound annual growth rate of 33.0% (FY2022 to FY2025).
- In prior years, Lexeo Therapeutics' Current Assets was $126.12 million in FY2024 (+1.5%), $124.29 million in FY2023 (+55.3%) and $80.05 million in FY2022.
- The Q2 2026 figure stands as the highest quarterly Current Assets in data going back to Q4 2022.
- On a year-over-year basis, Current Assets has increased in each of the last three quarters, with growth averaging 52.5% over the last eight quarters.
- The strongest year-over-year quarter for Current Assets in the past five years was Q3 2024, with growth of 310.2%; the weakest was Q1 2025, with a decline of 46.9%.
- According to Business Quant data, Current Assets for the three prior quarters was $200.86 million (Q1 2026), $188.39 million (Q4 2025) and $127.79 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Lexeo Therapeutics | 246.87 Mn | 246.87 Mn | - | 217.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 217.91 Mn |
| Mar 31, 2026 | 200.86 Mn |
| Dec 31, 2025 | 188.39 Mn |
| Sep 30, 2025 | 127.79 Mn |
| Jun 30, 2025 | 140.06 Mn |
| Mar 31, 2025 | 105.27 Mn |
| Dec 31, 2024 | 126.12 Mn |
| Sep 30, 2024 | 159.46 Mn |
| Jun 30, 2024 | 177.15 Mn |
| Mar 31, 2024 | 198.09 Mn |
| Dec 31, 2023 | 124.29 Mn |
| Sep 30, 2023 | 38.87 Mn |
| Dec 31, 2022 | 80.05 Mn |
API Access
Lexeo Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();